← IOVANCE BIOTHERAPEUTICS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net loss | ($52.9m) | ($92.1m) | ($123.6m) | ($197.6m) | ($259.6m) | ($342.3m) | ($395.9m) | ($444.0m) | ($372.2m) | ($391.0m) | — | |
| Net Income (Loss) Attributable to Parent | ($52.9m) |
($92.1m)
-74.05%
|
($123.6m)
-34.23%
|
($197.6m)
-59.86%
|
($259.6m)
-31.40%
|
($342.3m)
-31.85%
|
($395.9m)
-15.67%
|
($444.0m)
-12.16%
|
($372.2m)
+16.18%
|
($391.0m)
-5.05%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($102.3m) |
($92.1m)
+10.05%
|
($123.6m)
-34.23%
|
— | — | — | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | $978k | $952k | $956k | $1.2m | $1.1m | $3.1m | $9.3m | $11.6m | $12.0m | $12.9m | $45.0m | |
| Depreciation | $1.0m | $1.0m | $1.0m | $1.2m | $1.1m | $3.1m | $9.3m | — | — | — | $21.9m | |
| Amortization of Intangible Assets | — | — | — | — | — | — | $0 | $9.8m | $21.2m | $23.1m | — | |
| Amortization of right of use asset | — | — | — | $7.0m | $7.6m | $10.9m | $11.8m | $11.7m | $10.4m | $11.4m | — | |
| Depreciation and amortization of property and equipment | — | $952k | $956k | $1.2m | $1.1m | $3.1m | $9.3m | $11.6m | $12.0m | $12.9m | $45.0m | |
| Deferred Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 | $0 | — | — | ($3.5m) | ($2.8m) | ($2.1m) | ($4.3m) | |
| Deferred tax (benefit) expense | — | — | — | — | — | — | — | ($3.5m) | ($2.8m) | ($2.1m) | — | |
| Share-based Payment Arrangement, Noncash Expense | $18.9m | $12.0m | $20.0m | $24.3m | $40.9m | $69.8m | $84.0m | $62.6m | $109.6m | $61.6m | $46.7m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $642k | $1.3m | $223k | $312k | $284k | — | $2.6m | $2.8m | $12.9m | $7.1m | — | |
| Share-based Payment Arrangement, Expense | $1.0m | $0 | — | — | — | — | — | — | — | — | $46.7m | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | $18.9m | $12.0m | $20k | $24.3m | $40.9m | $69.8m | $84.0m | $62.6m | $109.6m | $61.6m | $46.7m | |
| Stock-based compensation expense | $18.9m | $12.0m | $20.0m | $24.3m | $40.9m | $69.8m | $84.0m | $62.6m | $109.6m | $61.6m | $46.7m | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | — | — | — | — | — | $149k | $69.2m | $13.1m | ($42.2m) | |
| Trade accounts receivable | — | — | — | — | — | — | — | ($149k) | ($69.2m) | ($13.1m) | — | |
| Increase (Decrease) in Inventories | — | — | — | — | — | — | — | $10.1m | $39.9m | $14.2m | ($12.1m) | |
| Inventory Write-down | — | — | — | — | — | — | — | — | — | $13.4m | — | |
| Inventory | — | — | — | — | — | — | — | ($10.1m) | ($39.9m) | ($14.2m) | ($12.1m) | |
| Increase (Decrease) in Accounts Payable | ($250k) | $369k | $1.5m | $12.7m | ($3.0m) | $7.0m | $5.9m | $4.8m | ($7.8m) | ($6.7m) | ($5.5m) | |
| Acquisition of property and equipment included in accounts payable and accrued expenses | — | — | — | $122k | ($5.1m) | ($7.3m) | ($6.0m) | $4.1m | $7.4m | $8.5m | — | |
| Accrued expenses and other liabilities | $3.4m | $4.6m | $3.2m | $6.7m | $24.1m | $20.7m | ($4.7m) | $19.8m | $8.6m | $28.6m | — | |
| Prepaid expenses, other assets and long-term assets | ($2.8m) | ($875k) | ($2.1m) | ($3.3m) | ($6.7m) | $2.8m | ($2.1m) | ($10.1m) | ($2.1m) | ($8.0m) | — | |
| Net Cash Provided by (Used in) Operating Activities | ($32.7m) |
($78.7m)
-140.94%
|
($101.2m)
-28.64%
|
($158.9m)
-56.93%
|
($205.1m)
-29.11%
|
($227.9m)
-11.12%
|
($292.8m)
-28.44%
|
($361.8m)
-23.59%
|
($353.0m)
+2.44%
|
($302.4m)
+14.33%
|
($264.2m)
+12.64%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $1.5m | $1.0m | $1.2m | $6.9m | $46.8m | $37.6m | $20.4m | $22.3m | $11.1m | $33.8m | ($32.2m) | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | — | — | ($9k) | ($16k) | — | — | ($397k) | — | — | — | ($34k) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | — | — | — | — | — | — | — | ($44k) | ($34k) | |
| Cash, Cash Equivalents, and Short-term Investments | $166.5m | — | $386.4m | — | $635.0m | — | — | — | — | — | — | |
| Unrealized Gain (Loss) on Investments | — | — | — | — | ($201k) | ($620k) | ($301k) | $940k | $78k | $54k | — | |
| Accretion of discounts and premiums on investments | ($74k) | $19k | ($1.3m) | ($3.4m) | $1.9m | $6.0m | $474k | ($3.6m) | ($10.3m) | ($7.2m) | — | |
| Maturities of investments | $120.7m | $59.7m | $41.0m | $514.6m | $676.6m | $762.9m | $522.7m | $285.6m | $428.0m | $400.0m | — | |
| Purchase of investments | — | — | ($426.1m) | ($417.7m) | ($947.7m) | ($725.2m) | ($245.8m) | ($205.9m) | ($460.8m) | ($318.7m) | ($337.7m) | |
| Net unrealized loss on investments | — | — | — | — | ($201k) | ($620k) | ($301k) | $940k | $78k | $54k | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | — | $212.6m | — | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | $8.9m | $58.7m | ($386.3m) | $90.0m | ($317.9m) | $132k | $256.5m | ($155.2m) | ($96.4m) | $47.5m | ($44.9m) | |
| Cash flows from financing activities: | ||||||||||||
| Proceeds from Issuance of Long-term Debt | — | — | — | — | — | $1.0m | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | $95.7m | $53.7m | $398.8m | — | $567.0m | $203.2m | $189.5m | $463.3m | $397.3m | $306.3m | $292.4m | |
| Proceeds from the issuance of common stock under employee stock purchase plan | — | — | — | — | — | $1.6m | $1.7m | $2.4m | $3.0m | $1.5m | — | |
| Proceeds from the issuance of common stock upon exercise of options | $626k | $5.6m | $10.0m | $6.4m | $9.7m | $33.5m | $1.6m | $63k | $3.3m | $15k | — | |
| Proceeds from the issuance of common stock, net | $95.7m | $53.7m | $398.8m | — | $567.0m | $203.2m | $189.5m | $463.3m | $397.3m | $306.3m | — | |
| Conversion of convertible preferred stock to common stock | $3k | $1k | $1k | $2k | — | ($1k) | — | — | — | $1k | — | |
| Net Cash Provided by (Used in) Financing Activities | $96.9m |
$58.7m
-39.44%
|
$424.3m
+622.99%
|
$6.1m
-98.56%
|
$576.4m
+9301.76%
|
$239.3m
-58.49%
|
$190.2m
-20.53%
|
$463.0m
+143.47%
|
$390.7m
-15.62%
|
$300.8m
-23.01%
|
$287.9m
-4.30%
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash | — | $38.7m | ($63.2m) | ($62.7m) | $53.4m | $11.5m | $153.8m | ($56.8m) | ($59.3m) | $47.0m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | $38.7m | ($63.2m) | ($62.7m) | $53.4m | $11.5m | $153.8m | ($56.8m) | ($59.3m) | $47.0m | $117.2m | |
| Cash, Cash Equivalents and Restricted Cash Beginning of Period | — | $145.4m | $82.2m | $19.4m | $72.9m | $84.3m | $238.2m | $181.3m | $122.1m | $169.1m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $38.7m | ($63.2m) | $19.4m | $72.9m | $84.3m | $238.2m | $181.3m | $122.1m | $169.1m | $117.2m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | — | ($2.7m) | ($541k) | $1.1m | ($440k) | |
| Effect of foreign exchange rate changes | — | — | — | — | — | — | — | ($2.7m) | ($541k) | $1.1m | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $626k | $5.6m | $10.0m | $6.4m | $9.7m | $33.5m | $1.6m | $63k | $3.3m | $15k | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $0 | $0 | $0 | — | — | — | — | — | — | — | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | — | — | — | — | ($70k) | $175k | $238k | — | |
| Gain (Loss) on Termination of Lease | — | — | — | — | — | — | — | — | $5.6m | — | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | $336k | — | — | — | — | — | — | — | |
| General and Administrative Expense | $25.6m | $21.3m | $28.4m | $40.8m | $60.2m | $83.7m | $104.1m | $106.9m | $153.0m | $152.3m | — | |
| Investment Income, Interest | $745k | $813k | $4.7m | $9.3m | $2.4m | $451k | $3.0m | $13.0m | $20.3m | $10.3m | — | |
| Operating Expenses | $53.6m | $92.9m | $128.3m | $206.9m | $261.9m | $342.7m | $398.9m | — | — | — | — | |
| Unrealized foreign exchange loss | — | — | — | — | — | — | — | $70k | ($175k) | ($238k) | — | |
| Loss on asset disposals | — | — | — | — | — | — | — | — | $7.4m | $44k | — | |
| Operating lease liabilities | — | — | — | ($6.1m) | ($11.5m) | ($5.9m) | ($1.9m) | ($10.8m) | ($12.1m) | ($10.9m) | — | |
| Cash paid for acquisition, including contingent consideration, net of cash acquired | — | — | — | — | — | — | — | ($212.6m) | ($52.6m) | — | — | |
| Tax payments related to shares withheld for vested restricted stock units | ($642k) | ($1.3m) | ($223k) | ($312k) | ($284k) | — | ($2.6m) | ($2.8m) | ($12.9m) | ($7.1m) | — | |
| Lease liabilities arising from obtaining right-of-use asset from new leases | — | — | — | $14.8m | $46.0m | $17.3m | $553k | $177k | $2.3m | — | — | |
| Increase / (decrease) in lease liabilities due to obtaining/(reduction in) right-of-use assets from lease modifications | — | — | — | $4.8m | $826k | $7.8m | $15.3m | $1.0m | ($7.8m) | $2.1m | — |